{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T22:19:25Z","timestamp":1715552365932},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2004,4,13]]},"DOI":"10.1212\/wnl.62.7.1036","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T14:23:08Z","timestamp":1336918988000},"page":"1036-1037","update-policy":"http:\/\/dx.doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Aspirin"],"prefix":"10.1212","volume":"62","author":[{"given":"David C.","family":"Anderson","sequence":"first","affiliation":[{"name":"From the Department of Neurology (Dr. Anderson), Hennepin County Medical Center, University of Minnesota, Minneapolis; and Department of Medicine (Neurology) (Dr. Goldstein), Duke Center for Cerebrovascular Disease, Center for Clinical Health Policy Research, Duke University and Durham VAMC, NC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry B.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Dr. Anderson), Hennepin County Medical Center, University of Minnesota, Minneapolis; and Department of Medicine (Neurology) (Dr. Goldstein), Duke Center for Cerebrovascular Disease, Center for Clinical Health Policy Research, Duke University and Durham VAMC, NC."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","unstructured":"American Heart Association. Heart disease and stroke statistics\u20142003 update [online]. Available at: http:\/\/www.americanheart.org\/Heart_and_Stroke_A_Z_Guide\/strokes.html"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7329.71"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000020190.45892.75"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.30.9.1991"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.1.13"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1.300"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000113757.34662.AA"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000063141.24491.50"},{"key":"e_1_3_1_10_2","first-page":"56802","volume":"63","year":"1998","unstructured":"Food & Drug Administration. Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products. Federal Register. 1998; 63: 56802\u201356819.","journal-title":"Federal Register"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.62.7.1036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:10:00Z","timestamp":1711534200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.62.7.1036"}},"subtitle":["It\u2019s hard to beat"],"short-title":[],"issued":{"date-parts":[[2004,4,13]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,4,13]]}},"alternative-id":["10.1212\/WNL.62.7.1036"],"URL":"https:\/\/doi.org\/10.1212\/wnl.62.7.1036","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,13]]}}}